Uniquity Bio, a clinical-stage drug development company focused on immunology and inflammation and backed by Blackstone Life Sciences, today announced the appointment of Jason Moore as Senior Vice President, Regulatory & Quality. A seasoned biopharma executive, Mr. Moore has led drug development programs across multiple therapeutic areas and every stage of clinical development, with a history of executing programs for regulatory and commercial success.
